This page is part of the discussion forum, edits are actively encouraged!
Visiting Committee Visit Planning '08
- Increase number of electives
- From Survey:
- Statistics Class focused on Biology
- Tissue Engineering
- Graduate Lab Technique class:Imaging,Biochemistry,Basic Biology
- Cellular,Physiological,Organ level biology
- Mathematical modeling
Advisor Selection Process
- First year funding is critical, need for more fellowships?
- Students are agreed that the flexibility permitted by 2 semesters of guaranteed funding attracts many to the department.
- Working for two advisors - one in BE, one not. Is this working well for people?
- Process: Students would appreciate a list of available faculty (those who have space), but are otherwise happy with the process.
What research areas are lacking?
- Synthetic Biology
- From 2006 survey:
- Strengthen core subjects already emphasized
- Metabolic engineering
- Currently de-centralized,lack of collaborations?,social interactions?
- Labs in the Biology Building can definitely feel isolated from department
- Tech Square people generally happy over there, would not necessarily want to move
- Not enough space for new faculty
BE Department Staff
- Compared to other engineering departments, less staff; asking them to wear a lot of hats
- minimal web site activity, low student input, other departments seem to do more self-promotion (related to staff issue)
- BE: 7, ChemE: at least 9, EECS: at least 9
- ChemE has dedicated Web Site developer, Communications/Events people
- EECS has Alumni Relations
- Current grads are finding jobs, but new web portal might offer more help
- How to attract recruiters - currently Merck actively recruits, but few others
- Alumni contacts/database? - Dan says will try to incorporate into web portal, infinite connection has many
- Where are current graduates working? (John Kisiday - faculty at Colorado State, Nora Szasz - start-up, Jon Fitzgerald - Merrimack, Jon Szafranski - Guidant, Laurel - industry, Ali K - HST faculty, Jenny Lee - Wyeth, Csani Varga - Millenium, Dan Erickson - Sales/Consulting, Kevin Janes - post-doc/academic, Maxine Jonas- BioTrove, Nate Tedford- Epitome, Erik Krauland- Adimab, Inc., Kathryn Armstrong- Schrodinger, Inc., Ricardo Brau- L.E.K. Consulting, Jon Behr- PureTech Ventures, Helene Karcher - Novartis, Lisa Joslin - Merck, Sriram Kosuri - , Siddhartha Jain - Bristal-Myers Squibb, Ale Wolf-Yadlin - Post-doc Harvard, Rouzbeh Taghizadeh - Post-doc (now, not sure), Shawdee Eshghi - Post-doc UC Berkeley, Bambang Adiwijaya - Vertex, Jan Lammerding - Lecture position (i think) at Harvard, Marita Barth - post-doc, Megan McBee-Post-doc)
- Is the department paying sufficient attention to helping people get academic/post-doc positions?
- Are more people going to biotech or pharma in industry? Is BE training better received in one sector versus the other?
- Increase in number of semesters as TA?
Do the younger years feel the same association and investment in the department that the older years felt? If not, is this unavoidable as the department grows and matures? Can anything be done about this? Centralization of labs, common areas?
Visiting Committee Meeting 2006
Notes from previous Visiting Committee Meeting - have these issues been addressed significantly?